INOTUZUMAB OZOGAMICIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 00:28:34 UTC 2023` Edited by `admin` on `Sat Dec 16 00:28:34 UTC 2023`
Protein Type	MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type	IGG4
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	P93RUU11P7
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

INOTUZUMAB OZOGAMICIN

Official Name

English

WAY-207294

Code

English

INOTUZUMAB OZOGAMICIN [MART.]

Common Name

English

Inotuzumab ozogamicin [WHO-DD]

Common Name

English

CMC-544

Code

English

IMMUNOGLOBULIN G4 (ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL G544 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL G544 .KAPPA.-CHAIN, DIMER, METHYL ((1R,4Z,8S,13E)-8-((2-O-(4-(ACETYLETHYLAMINO)-2,4-DIDEOXY-3-O-METHYL-.ALPHA.-L-THREO-PENTOPY

Common Name

English

BESPONSA

Brand Name

English

INOTUZUMAB OZOGAMICIN [MI]

Common Name

English

INOTUZUMAB OZOGAMICIN [JAN]

Common Name

English

INOTUZUMAB OZOGAMICIN [USAN]

Common Name

English

PF-05208773

Code

English

inotuzumab ozogamicin [INN]

Common Name

English

INOTUZUMAB OZOGAMICIN [PURPLE BOOK CDER]

Common Name

English

Classification Tree Code System Code

EU-Orphan Drug

EU/3/13/1127

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

NDF-RT

N0000193617

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

NCI_THESAURUS

C155713

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

WHO-ATC

L01XC26

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

FDA ORPHAN DRUG

391413

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

Code System Code Type Description

DRUG CENTRAL

5247

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

INN

8574

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

DAILYMED

P93RUU11P7

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

MESH

C480122

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

MERCK INDEX

m12031

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

NCI_THESAURUS

C71542

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

USAN

QQ-54

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

RXCUI

1942950

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

WIKIPEDIA

INOTUZUMAB OZOGAMICIN

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

EVMPD

SUB33081

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

FDA UNII

P93RUU11P7

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

CAS

635715-01-4

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

LACTMED

Inotuzumab Ozogamicin

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

ChEMBL

CHEMBL2108611

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

SMS_ID

100000125897

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

DRUG BANK

DB05889

Created by admin on Sat Dec 16 00:28:34 UTC 2023 , Edited by admin on Sat Dec 16 00:28:34 UTC 2023

PRIMARY

From	To
1_20	1_94
2_20	2_94
2_133	4_219
2_146	2_202
2_260	2_320
1_133	3_219
2_366	2_424
3_23	3_93
3_139	3_199
4_23	4_93
4_139	4_199
1_146	1_202
1_225	2_225
1_228	2_228
1_260	1_320
1_366	1_424

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_296
N	2_296

Related Record Type Details


					RCH7C9TW12

B-CELL RECEPTOR CD22

TARGET -> INHIBITOR


					UC47AV3PU8

CONJUGATE COMPONENT->CONJUGATE


					EDM24GA51F

TOXIN -> CONJUGATE

Related Record Type Details


					UC47AV3PU8

METABOLITE -> PARENT


					3FJ2DCE5R2

N-ACETYL-.GAMMA.-CALICHEAMICIN DIMETHYLHYDRAZIDE

METABOLITE ACTIVE -> PARENT

Related Record Type Details


					P93RUU11P7

INOTUZUMAB OZOGAMICIN

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL